Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan-Feb;32(1):179-184.
doi: 10.21873/invivo.11222.

Totally Implantable Central Venous Port Catheters: Radiation Exposure as a Function of Puncture Site and Operator Experience

Affiliations

Totally Implantable Central Venous Port Catheters: Radiation Exposure as a Function of Puncture Site and Operator Experience

Martin Jonczyk et al. In Vivo. 2018 Jan-Feb.

Abstract

Background: Totally implantable central venous port systems provide a safe and effective, long-term means of access for administration of hyperosmolar, local irritant medication, such as chemotherapy, antibiotics and parenteral nutrition.

Aim: To evaluate the combination of access site and level of experience on fluoroscopy times (FT) and dose area products (DAP) during implantation of port catheters in a large patient population.

Materials and methods: A total of 1,870 patients (992 women, 878 men; age: 61±13.14 years) were reviewed investigating two groups of junior (≤50 implantations) and senior (>50) radiologists.

Results: Senior radiologists required less FT/DAP (0.24 s/57.3 μGy m2 versus 0.43 s/68.2 μGy m2, respectively; p<0.001). Right jugular vein access required the least FT/DAP (0.25 s/56.15 μGy m2) and right-sided implantation lower FT/DAP (right: 0.26 s/56.4 μGy m2, left: 0.40 s/85.10 μGy m2, p<0.001).

Conclusion: Due to DAP/FT reductions, the right jugular vein seems to be the most favorable implantation side for port systems. For further dose reduction, residents should be well-trained.

Keywords: Totally implantable central venous port systems; dose area product; fluoroscopy time; radiation exposure; training.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Fluoroscopy time (FT) (A) and dose area product (DAP) (B) according to radiologist experience. Senior >50 implantations; Junior ≤50 implantations.
Figure 2
Figure 2. Fluoroscopy time (FT) (A) and dose area product (DAP) (B) according to puncture site. VJIL: Left internal jugular vein, VJIR: right internal jugular vein, VSCL: left subclavian vein, VSCR: right subclavian vein.
Figure 3
Figure 3. Fluoroscopy time (FT) (A) and dose area product (DAP) (B) according to access side.

Similar articles

Cited by

References

    1. Viana Taveira MR, Lima LS, de Araujo CC, de Mello MJ. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study. Pediatr Blood Cancer. 2017;64(2):336–342. - PubMed
    1. Goltz JP, Noack C, Petritsch B, Kirchner J, Hahn D, Kickuth R. Totally implantable venous power ports of the forearm and the chest: Initial clinical experience with port devices approved for high-pressure injections. Br J Radiol. 2012;85(1019):e966–972. - PMC - PubMed
    1. Gebauer B, El-Sheik M, Vogt M, Wagner H-J. Combined ultrasound and fluoroscopy guided port catheter implantation – high success and low complication rate. European Journal of Radiology. 2009;69(3):517–522. - PubMed
    1. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery. 1982;92(4):706–712. - PubMed
    1. Morris SL, Jaques PF, Mauro MA. Radiology-assisted placement of implantable subcutaneous infusion ports for long-term venous access. Radiology. 1992;184(1):149–151. - PubMed

LinkOut - more resources